Why should healthspan technologies be a priority for investors? Chief Investment Officer of Hevolution Foundation, Dr. William Greene tells us why. 

To connect with Dr. Greene, find him on LinkedIn here.

To learn more about Hevolution Foundation, find their website here.

A huge shoutout to the APCO and Hevolution teams for scheduling and making this happen. Thank you!
 
Key Takeaways:

1.  The solution to solving chronic diseases in aging populations lies in addressing the technological, care, and approach gaps. 

2. About 5% of people globally develop cancer in their lifetime and 100% of people develop chronic, debilitating diseases, which demonstrates that the market for healthspan technologies is vast and underserved. 

3. Thinking holistically from idea, science, and then translation is essential in the cause and treatment of diseases for patients.